Brief: Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln
21/08/2026 12:27
BRIEF-Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln Aug 21 (Reuters) - Shanghai Henlius Biotech HY profit RMB430.4 million
- H1 revenue RMB 3,588.2 million
Recent news on Shanghai Henlius Biotech
See all newsBrief: Shanghai Henlius Biotech Says Wenjie Zhang Resigns As Chairman
Brief: Shanghai Henlius Biotech Enters Collaboration And License Agreement With Amberstone Biosciences
Brief: Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA
China's Henlius H1 revenue jumps on drug sales, license income
Brief: Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln